Atezolizumab plus Bevacizumab Treatment Worsens Liver Reserve in Patients with Nafld/Nash-Associated Liver Cancer More than in Those with Non-nafld/Non-Nash-Associated Liver Cancer
Medicine and Pharmacology - Gastroenterology and Hepatology
supplementary.pptx (257.86KB )
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Alerts
Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.